Delivery Order SPE2DB20D3103-SPE2DB23FM9F5

Award Date 3/29/23
Potential Completion Date 3/30/23
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award for $21,960.00 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200 mg hydroxychloroquine tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,937.72 Firm Fixed Price delivery order is for the supply of 4,561,867 units of Hydroxychloroquine 200 mg tablets, with a completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hydroxychloroquine 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,408.15. The award date was March 28, 2022, with an ultimate completion date of March 29, 2022. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxychloroquine 200 mg tablets in 100-count bottles, with a ceiling value of $3,909.46 and a completion date of September 3, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,106.09 firm fixed price delivery order is for the supply of Plaquenil 200 mg tablets, with a completion date of May 30, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,101.97 firm fixed-price delivery order is for the pharmaceutical product Plaquenil 200 mg Tablet, with a completion date of June 5, 2023. The contract was awarded on June 2, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $64,160.87 firm fixed-price delivery order covers the supply of Plaquenil 200 mg tablets in 100-count bottles, with a performance period through April 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM9F5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, worth $2,041.27, is for the supply of 4,560,423,676 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of March 30, 2023 and is a firm fixed-price arrangement. This award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply programs. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:33 PM